Abstract
Background: Recently, whole exome sequencing identified heterozygous defects in the aggrecan (ACAN) gene in three families with short stature and advanced bone age.
Objective: We report a novel frameshift mutation in ACAN in a family with dominantly inherited short stature, advanced bone age, and premature growth cessation. This is the first case of targeted sequencing of ACAN in this phenotype and confirms that ACAN sequencing is warranted in patients with this rare constellation of findings.
Results: We present a 5 1/2-year-old male with a family history of short stature in three generations. The maternal grandfather stands 144.5 cm (Ht SDS –4.7), mother 147.7 cm (Ht SDS –2.6), and index case 99.2 cm (Ht SDS –2.7). Our prepubertal patient has significant bone age advancement (bone age 8 years at chronologic age 5 1/2 years) resulting in a poor predicted adult height of 142 cm (Ht SDS –5.1). DNA sequencing identified a novel heterozygous variant in ACAN, which encodes aggrecan, a proteoglycan in the extracellular matrix of growth plate and other cartilaginous tissues. The mutation (p.Gly1797Glyfs*52) results in premature truncation and presumed loss of protein function.
Conclusion: Mutations in the ACAN gene should be included in the differential diagnosis of the child with idiopathic short stature or familial short stature and bone age advancement.
References
1. Rose SR, Vogiatzi MG, Copeland KC. A general pediatric approach to evaluating a short child. Pediatr Rev 2005;26:410–20.10.1542/pir.26.11.410Search in Google Scholar
2. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 2008;93:4210–17.10.1210/jc.2008-0509Search in Google Scholar
3. Dauber A, Rosenfeld RG, Hirschhorn JN. Genetic evaluation of short stature. J Clin Endocrinol Metab 2014;99:3080–92.10.1210/jc.2014-1506Search in Google Scholar
4. Nilsson O, Guo MH, Dunbar N, Popovic J, Flynn D, et al. Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations. J Clin Endocrinol Metab 2014;99:E1510–8.10.1210/jc.2014-1332Search in Google Scholar
5. Dauber A, Stoler J, Hechter E, Safer J, Hirschhorn JN. Whole exome sequencing reveals a novel mutation in CUL7 in a patient with an undiagnosed growth disorder. J Pediatr 2013;162:202–4.10.1016/j.jpeds.2012.07.055Search in Google Scholar
6. Doege KJ, Sasaki M, Kimura T, Yamada Y. Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms. J Biol Chem 1991;266:894–902.10.1016/S0021-9258(17)35257-2Search in Google Scholar
7. Kiani C, Chen L, Wu YJ, Yee AJ, Yang BB. Structure and function of aggrecan. Cell Res 2002;12:19–32.10.1038/sj.cr.7290106Search in Google Scholar PubMed
8. Stattin EL, Wiklund F, Lindblom K, Onnerfjord P, Jonsson BA, et al. A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans. Am J Hum Genet 2010;86:126–37.10.1016/j.ajhg.2009.12.018Search in Google Scholar PubMed PubMed Central
9. Nilsson O, Marino R, De Luca F, Phillip M, Baron J. Endocrine regulation of the growth plate. Horm Res 2005;64:157–65.10.1159/000088791Search in Google Scholar PubMed
10. Domowicz MS, Cortes M, Henry JG, Schwartz NB. Aggrecan modulation of growth plate morphogenesis. Dev Biol 2009;329:242–57.10.1016/j.ydbio.2009.02.024Search in Google Scholar PubMed PubMed Central
11. Watanabe H, Yamada Y. Chondrodysplasia of gene knockout mice for aggrecan and link protein. Glycoconj J 2002;19:269–73.10.1023/A:1025344332099Search in Google Scholar
12. Anderson IJ, Tsipouras P, Scher C, Ramesar RS, Martell RW, et al. Spondyloepiphyseal dysplasia, mild autosomal dominant type is not due to primary defects of type II collagen. Am J Med Genet 1990;37:272–6.10.1002/ajmg.1320370223Search in Google Scholar PubMed
13. Gleghorn L, Ramesar R, Beighton P, Wallis G. A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis. Am J Hum Genet 2005;77:484–90.10.1086/444401Search in Google Scholar PubMed PubMed Central
14. Stattin EL, Tegner Y, Domellof M, Dahl N. Familial osteochondritis dissecans associated with early osteoarthritis and disproportionate short stature. Osteoarthritis Cartilage 2008;16:890–6.10.1016/j.joca.2007.11.009Search in Google Scholar PubMed
15. Tompson SW, Merriman B, Funari VA, Fresquet M, Lachman RS, et al. A recessive skeletal dysplasia, SEMD aggrecan type, results from a missense mutation affecting the C-type lectin domain of aggrecan. Am J Hum Genet 2009;84:72–9.10.1016/j.ajhg.2008.12.001Search in Google Scholar PubMed PubMed Central
16. Aspberg A. The different roles of aggrecan interaction domains. J Histochem Cytochem 2012;60:987–96.10.1369/0022155412464376Search in Google Scholar PubMed PubMed Central
17. Guo MH, Shen Y, Walvoord EC, Miller TC, Moon JE, et al. Whole exome sequencing to identify genetic causes of short stature. Horm Res Paediatr 2014;82:44–52.10.1159/000360857Search in Google Scholar PubMed PubMed Central
Supplemental Material
The online version of this article (DOI: 10.1515/jpem-2014-0450) offers supplementary material, available to authorized users.
©2015 by De Gruyter
